- DUSA Pharmaceuticals
-
DUSA Pharmaceuticals, Inc. Type Public (NASDAQ: [1] DUSA) Industry Pharmaceuticals,
HealthcareHeadquarters Wilmington, Massachusetts, USA Key people D. Geoffrey Shulman, MD, FRCP, Founder, Chairman, and CSO
Robert F. Doman, President and CEOProducts Levulan Kerastick,
BLU-U,
ClindaReach,
Psoriatec,
METED Shampoo,
NicomideWebsite http://www.dusapharma.com/ DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA) is pharmaceutical company based in Wilmington, Massachusetts that specializes in dermatology products. The major focus of the company includes medications used in the treatment of actinic keratoses and acne.
In the first quarter of 2006, DUSA Pharmaceuticals obtained Sirius Laboratories Inc. in a merger estimated to be worth 30 million dollars. Sirius was a privately held dermatology specialty pharmaceuticals company founded by Dr. Joel E. Bernstein in 2000 dedicated to the treatment of acne vulgaris and acne rosacea.[1]
External links
References
- ^ "DUSA Pharmaceuticals Closes Acquisition of Sirius Laboratories". BNET. 2006-04-14. http://findarticles.com/p/articles/mi_m0EIN/is_2006_March_14/ai_n26792987. Retrieved 2008-08-26.
Categories:- Companies listed on NASDAQ
- Wilmington, Massachusetts
Wikimedia Foundation. 2010.